Literature DB >> 33578002

Clinical implementation and initial experience of real-time motion tracking with jaws and MLC during helical tomotherapy delivery.

Guang-Pei Chen1, An Tai2, Lindsay Puckett2, Elizabeth Gore2, Sara Lim2, Timothy Keiper2, Candice Johnstone2, Monica Shukla2, Colleen Lawton2, X Allen Li2.   

Abstract

PURPOSE: This work reports the clinical implementation of a real-time motion tracking and correction system using dynamic multileaf collimator (MLC) and jaws during helical tomotherapy delivery (Synchrony on Radixact, Accuray Inc).
MATERIALS AND METHODS: The first clinical Synchrony on Radixact system was recently installed and tested at our institution. Various clinical workflows, including fiducial implantation, CT simulation, treatment planning, delivery quality assurance (DQA), treatment simulation, and delivery, for both fiducial-free and fiducial-based motion tracking methods were developed. Treatment planning and delivery data from initial patients, including dosimetric benefits, real-time target detection, model building, motion tracking accuracy, delivery smoothness, and extra dose from real-time radiographic imaging, were analyzed.
RESULTS: The Synchrony on Radixact system was tested to be within its performance specifications and has been used to treat 10 lung (fiducial-free) and 5 prostate (fiducial-based) cancer patients so far in our clinic. The success of these treatments, especially for fiducial-free tracking, depends on multiple factors including careful selection of the patient, appropriate setting of system parameters, appropriate positioning of the patient and skin markers, and use of treatment simulation. For the lung tumor cases, the difficulties in model building due primarily to the changes of target detectability and/or respiration patterns, were observed, which led to important system upgrades including the addition of a treatment delivery simulation capability. Motion tracking metrics for all treated patients were within specifications, e.g., (1) DQA passing rates >95%, (2) extra dose from radiograph < 0.5% of the prescription dose, (3) average Potential Diff, Measured Δ, Rigid Body within 6.5, 2.9 and 3.9 mm, respectively.
CONCLUSIONS: Practical workflows for the use of the first clinical motion tracking and correction system in helical tomotherapy delivery have been developed and the system has now been successfully implemented in our clinic for treating lung and prostate cancer patients.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Year:  2021        PMID: 33578002     DOI: 10.1016/j.prro.2021.01.010

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  5 in total

1.  Effects of variable-width jaw motion on beam characteristics for Radixact Synchrony®.

Authors:  William S Ferris; Wesley S Culberson; Jennifer B Smilowitz; John E Bayouth
Journal:  J Appl Clin Med Phys       Date:  2021-03-29       Impact factor: 2.102

2.  Using 4D dose accumulation to calculate organ-at-risk dose deviations from motion-synchronized liver and lung tomotherapy treatments.

Authors:  William S Ferris; Edward H Chao; Jennifer B Smilowitz; Randall J Kimple; John E Bayouth; Wesley S Culberson
Journal:  J Appl Clin Med Phys       Date:  2022-04-29       Impact factor: 2.243

3.  Radiotherapy for head and neck tumours using an oral fixation and parameter acquisition device and TOMO technology: a randomised controlled study.

Authors:  Xiaofang Zhang; Tianlu Wang; Xinyan Xiao; Xia Li; Chen Yu Wang; Bo Huang; Lei He; Yingqiu Song
Journal:  BMJ Open       Date:  2021-11-12       Impact factor: 2.692

4.  Technical note: Tracking target/chest relationship changes during motion-synchronized tomotherapy treatments.

Authors:  William S Ferris; Wesley S Culberson; John E Bayouth
Journal:  Med Phys       Date:  2022-04-20       Impact factor: 4.506

5.  A first report of tumour-tracking radiotherapy with helical tomotherapy for lung and liver tumours: A double case report.

Authors:  Wataru Okada; Hiroshi Doi; Masao Tanooka; Keisuke Sano; Kenji Nakamura; Yusuke Sakai; Mayuri Shibata; Masahiro Tanaka
Journal:  SAGE Open Med Case Rep       Date:  2021-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.